Now, effective painkillers without dangerous side effects

Image
Press Trust of India Berlin
Last Updated : Mar 04 2017 | 1:22 PM IST
Scientists in Germany have discovered a new way of developing painkillers that are more effective and without dangerous side effects.
Researchers including those from Charite Universitatsmedizin Berlin used computational simulation to analyse interactions at opioid receptors - the cell's docking sites for painkillers.
When used in an animal model, their prototype of a morphine-like molecule was able to produce substantial pain relief in inflamed tissues.
However, healthy tissues remained unaffected, suggesting that the severe side effects currently associated with these types of painkillers might be avoided.
Opioids are a class of strong pain killers. They are mainly used to treat pain associated with tissue damage and inflammation, such as that caused by surgery, nerve damage, arthritis or cancer.
Common side effects associated with their use include drowsiness, nausea, constipation and dependency and, in some cases, respiratory arrest.
"By analysing drug-opioid receptor interactions in damaged tissues, as opposed to healthy tissues, we were hoping to provide useful information for the design of new painkillers without harmful side effects," said Professor Christoph Stein of the Department of Anesthesiology and Surgical Critical Care Medicine.
Researchers with the help of innovative computational simulations were able to analyse morphine-like molecules and their interactions with opioid receptors.
They were able to successfully identify a new mechanism of action, which is capable of producing pain relief only in the desired target tissues - those affected by inflammation.
The finding was published in the journal Science.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 04 2017 | 1:22 PM IST

Next Story